1 / 10

Deepening Topics

Deepening Topics. QM in Clinical studies. Clinical Studies. Regulations EU- Directive , e.g. 2001/20/EC Drug Law Medical Device Act GCP-Regulation. Clinical Studies. Standards ISO 14155:2012 Clinical investigation of medical devices for human subjects - Good clinical practice

silas
Download Presentation

Deepening Topics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Deepening Topics QM in Clinical studies

  2. Clinical Studies Regulations • EU-Directive, e.g. 2001/20/EC • Drug Law • Medical Device Act • GCP-Regulation

  3. Clinical Studies Standards • ISO 14155:2012 Clinical investigation of medical devices for human subjects - Good clinical practice • „International Conference on Harmonisationof Technical Requirementsfor Registration of Pharmaceuticals for Human Use (ICH)“ • Guideline forGood Clinical Practice (GCP) • ISO 9001:2008 Chapter 7.3 Design and Development • EN 15224:2012 Chapter 7.3 Design and Development

  4. Clinical Studies Study managementpersons Sponsor Federal agencies Principalinvestigator andhisDeputy--------------------------personresponsibleforstudyconduct Study assistance/Study nurse

  5. Clinical Studies Sponsor • Natural or legal person • Responsibilitiesforinitiation, organisation and financingof the clinicalstudy • Designates principalinvestigator, also in caseofmulticenterstudiesorifmoreinvestigatorsinvolved • Reporting to Federal agencies and ethicalcommittee: • e.g. undesirablesideeffects • e.g. individual casereporting on severesideeffects

  6. Clinical Studies PrincipalInvestigator • Responsibleforstudyconduct • At least 2 yearsexperience in clincalstudiesofdrugs • Regular exchange and cooperationwithstudyassistance • Designates qualifiedcooperatorsof the studygroup, leads and monitorsthem • Designates at least onedeputywithequalqualifications • Responsibleforcompliancewith GCP • Reports undesirablesideeffectstosponsor

  7. Clinical Studies Investigator • Designatedbyprincipalinvestigator • Hastoprovespecificfurthereducation in studies Position canbetaken also bytheprincipalinvestigatorStudy secretariate • Designatedpersonsfor the secretariate and definedrooms, in which the documentationofthestudyconductandthearchivingof the documentsistakingplace. Compliance with GCP rules • Fromthere the communicationwith the studyconductingcooperatorsisorganised • Must beinformedaboutcriticalresults

  8. Clinical Studies Study assistence (Study nurse) • Qualification • Special professional training, e.g. MTA (medicaltechnicalassistance) or a specialqualifiednurse • Plus specialtrainingforstudyassistance • Contribution in studyconduct • Recruites, registers, assistsin thepatientinformedconsentCaresforpatients and post-treatment care • Organisation, coordinationof e.g. diagnostic, laboratory • Elicitation and documentation • Preparesandcooperatesin audits and at the inspectionsofauthorities

  9. Clinical Studies Federal authorities • BfArM: • Admission-licenceof human drugs • Handling atnotificationsofsevereadverseevents • GCP-inspectors: Auditing ofrooms, equipment, documentation, informedconsent, insurance, QM-system • GLP-Authority in the Federal instituteforriskevaluation: Conducts GLP-inspections Ethical-committeeisindependent Board: • For the Safety and Welfareof the studypatients

  10. Clinical Studies Clinical trailprotocol • Describesintentions, planning, methods, statisticalconsiderations and organisationof a trial • Requirementsfor the protocol in ISO 14155:2012 Publicationofresults • Favourableaswellas negative resultshavetobepublished • Reporting ofresultsaccordingto the GCP-requirements

More Related